These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32560526)

  • 1. The Application of Structural Retinal Biomarkers to Evaluate the Effect of Intravitreal Ranibizumab and Dexamethasone Intravitreal Implant on Treatment of Diabetic Macular Edema.
    Ceravolo I; Oliverio GW; Alibrandi A; Bhatti A; Trombetta L; Rejdak R; Toro MD; Trombetta CJ
    Diagnostics (Basel); 2020 Jun; 10(6):. PubMed ID: 32560526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
    Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
    Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
    Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
    Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids.
    Vujosevic S; Toma C; Villani E; Muraca A; Torti E; Florimbi G; Leporati F; Brambilla M; Nucci P; De Cilla' S
    Acta Diabetol; 2020 Mar; 57(3):287-296. PubMed ID: 31541333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of Serous Macular Detachment After Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema.
    Ozdemir MH; Elbay A; Kirik F; Ekinci C; Koytak A
    J Ocul Pharmacol Ther; 2019 Dec; 35(10):558-564. PubMed ID: 31647365
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effect of ranibizumab and dexamethasone implant on serous retinal detachment in diabetic macular edema.
    Demircan A; Ozkaya A; Alkin Z; Kemer B; Yesilkaya C; Demir G
    J Fr Ophtalmol; 2018 Oct; 41(8):733-738. PubMed ID: 30213609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
    BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome.
    Vadalà M; Sunseri Trapani V; Guarrasi G; Ventura N; Castellucci M; Cillino S
    Clin Ophthalmol; 2020; 14():2657-2665. PubMed ID: 32982158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dexamethasone treatment on serous retinal detachment in ranibizumab-resistant diabetic macular edema.
    Bayat AH; Elçioğlu MN
    Ther Adv Ophthalmol; 2020; 12():2515841420971936. PubMed ID: 33225213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the short-term effect of aflibercept and dexamethasone implant on serous retinal detachment in the treatment of naive diabetic macular edema.
    Bolukbasi S; Cakir A; Erden B; Karaca G
    Cutan Ocul Toxicol; 2019 Dec; 38(4):401-405. PubMed ID: 31438736
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.
    Manousaridis K; Peter S; Mennel S
    Int Ophthalmol; 2017 Feb; 37(1):47-53. PubMed ID: 27043320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.
    Ozkaya A; Tarakcioglu HN; Tanir I
    Optom Vis Sci; 2018 Dec; 95(12):1149-1154. PubMed ID: 30451802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
    Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
    Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
    Gu X; Yu X; Song S; Dai H
    Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience.
    Hsia NY; Lin CJ; Chen HS; Chang CH; Bair H; Lai CT; Lin JM; Chen WL; Tien PT; Wu WC; Tsai YY
    Front Med (Lausanne); 2021; 8():649979. PubMed ID: 33996856
    [No Abstract]   [Full Text] [Related]  

  • 17. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and Late Switch from Ranibizumab to an Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema in the Event of a Poor Anatomical Response.
    Demir G; Ozkaya A; Yuksel E; Erdogan G; Tunc U; Celal Ocal M; Sakır Goker Y
    Clin Drug Investig; 2020 Feb; 40(2):119-128. PubMed ID: 31768784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life outcomes of intravitreal ranibizumab, aflibercept, and dexamethasone implant administrations in patients with treatment-naïve diabetic macular edema.
    Korkmaz A; Karti O; Zengin MO; Yuksel B; Kusbeci T
    Saudi J Ophthalmol; 2022; 36(3):327-334. PubMed ID: 36276250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.